Forwarded from Anna Q
💉⚠️疫苗灾难区⚠️💉
Kym Whitehead 🪦又一个支持疫苗者在全面接种疫苗后突然死亡。（2022年11月）
(女子告诉反疫苗接种者 "去你的"--她刚刚被发现死在她的公寓里。）
"没有什么简单的方法可以告诉你这个。昨晚，警察来到我家门口告诉我，金茉被发现在她的公寓里没有反应。她的男友杰森在无法通过电话联系她后发现了她。我们还没有关于她死因的任何细节。首尔和我完全处于震惊之中，很难处理所发生的事情。"
Kym Whitehead 🪦又一个支持疫苗者在全面接种疫苗后突然死亡。（2022年11月）
(女子告诉反疫苗接种者 "去你的"--她刚刚被发现死在她的公寓里。）
"没有什么简单的方法可以告诉你这个。昨晚，警察来到我家门口告诉我，金茉被发现在她的公寓里没有反应。她的男友杰森在无法通过电话联系她后发现了她。我们还没有关于她死因的任何细节。首尔和我完全处于震惊之中，很难处理所发生的事情。"
CNA presenter Julie Yoo feeling better after fainting live on air: Mediacorp - CNA
#疫苗灾难
🇸🇬🥕🩸
https://www.channelnewsasia.com/singapore/cna-presenter-julie-yoo-fainting-live-air-asia-tonight-feeling-better-3057911
#疫苗灾难
🇸🇬🥕🩸
https://www.channelnewsasia.com/singapore/cna-presenter-julie-yoo-fainting-live-air-asia-tonight-feeling-better-3057911
CNA
CNA presenter Julie Yoo feeling better after fainting live on air: Mediacorp
SINGAPORE: CNA presenter Julie Yoo is feeling better after fainting live on air on Wednesday (Nov 9) evening, said Mediacorp. Ms Yoo is covering the United Nations-led COP27 climate talks in Sharm El-Sheikh, Egypt from Nov 6 to Nov 18. She was live on CNA's…
Forwarded from .
Buoyed by the successful global marketing of its COVID-19 vaccines, Pfizer is teeing up to dominate the Maternal Bivalent Respiratory Syncytial Virus (RSV) Vaccine
market even as OB-GYNs on the front lines of maternal care sound the alarm about the COVID-19 shots’ infanticidal fallout.
The FDA allowed Pfizer to “stop the [RSV] study short,” halting enrollment at about 7,400 participants — though the trial was supposed to involve 10,000 pregnant women. Signaling a regulatory willingness to speed up approval not only for Pfizer’s RSV vaccine but also for a maternal Group B Streptococcus (GBS) vaccine the company is developing.
VAERS COVID Vaccine
Reproductive Health Related Reports
Through October 28, 2022
Link
COVID Vaccine Reports in Children
(Ages 6 mos.-17 years)
Link
market even as OB-GYNs on the front lines of maternal care sound the alarm about the COVID-19 shots’ infanticidal fallout.
The FDA allowed Pfizer to “stop the [RSV] study short,” halting enrollment at about 7,400 participants — though the trial was supposed to involve 10,000 pregnant women. Signaling a regulatory willingness to speed up approval not only for Pfizer’s RSV vaccine but also for a maternal Group B Streptococcus (GBS) vaccine the company is developing.
VAERS COVID Vaccine
Reproductive Health Related Reports
Through October 28, 2022
Link
COVID Vaccine Reports in Children
(Ages 6 mos.-17 years)
Link